CD
Codexis, Inc.
CDXS · NASDAQ
$1.36 +0.74% (+$0.01)
1M -16.46%
Market Cap $152.7M
P/E Ratio -
Div. Yield -
ROE 74.36%
Piotroski F-Score Weak
3/9Valuation
59 /100
Fair P/S 1.97x
P/B 4.63x
P/E N/A
Growth
0 /100
Declining Rev. growth 20.22%
Book val. growth 29.60%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 83.71%
FCF margin 15.68%
Net margin 39.55%
Quality
8 /100
Poor ROIC 22.74%
Asset turnover 0.65x
ROE 74.36%
Debt
29 /100
High Debt/Equity 2.20x
Int. coverage -22.72x
Current ratio 3.06x
Stability
7 /100
Unstable Beta 2.53x
Profitable years 0
Rev. volatility 34.00%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CDXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alison Moore
Employees
146
Headquarters
Redwood City
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report